Florida Gov. DeSantis suggests one dose of Pfizer vaccine may be enough

DeSantis pointed to an article in the Wall Street Journal --- it was an opinion piece written by neuroscientist Michael Segal.

Florida Gov. DeSantis suggests one dose of Pfizer vaccine may be enough

Gov. Ron DeSantis just a few days ago said that Americans need to unify behind the science that has led to the rapid development of vaccines. So it was a bit strange that DeSantis on Friday said that perhaps the number of Florida residents who receive COVID-19 vaccinations could be boosted --- by not following Pfizer Inc.’s recommended instructions for its vaccine candidate.

The federal government is imminently expected to announce its approval of Pfizer's vaccine candidate and, within 24 hours of approval, begin shipping the vaccine to Florida and other states. DeSantis said Florida will receive less of the supply than what was initially anticipated, so he came up with a possible way to stretch out the state’s innoculations.

Instead of giving two doses, as recommended by the pharmaceutical manufacturer, to high-risk populations such as nursing home residents and front-line hospital workers, perhaps one dose could do, the governor suggested Friday.

DeSantis pointed to an article in the Wall Street Journal --- it was an opinion piece written by neuroscientist Michael Segal --- about the efficacy of the one-dose approach. DeSantis referred to the second dose as a "booster" shot, echoing Segal's choice of words.

“Just get as many doses out there,” the governor said during a mental-health roundtable in Tampa on Friday. “I’m not sure that Pfizer would agree or FDA would agree, but I think just the point is, getting that first dose out really does make a difference, and I think you’ll see that.”

Pfizer said last month that its vaccine candidate had a 95 percent effectiveness in providing protection against the virus that causes COVID-19 when two doses are administered three weeks apart. Documents released by the federal government this week showed that the vaccine offers some protections after the first dose. Indeed, the vaccine had an effectiveness of more than 50 percent about a week after it was administered.

But according to the the federal Centers for Disease Control and Prevention, the only vaccine candidate under developent that doesn't require two doses is one being manufactured by Johnson & Johnson.

DeSantis, a close ally of President Donald Trump, told reporters Friday that he thought the vaccinations would be distributed to the state on a risk-adjusted basis, taking things such as the age of the state’s residents into consideration. That would have boded well for Florida, which has the nation's second-highest proportion of residents over the age of 65.

Instead, the government is allocating the vaccination on a per-capita basis, DeSantis said.

Support local journalism in these crazy days. Our small but mighty team is working tirelessly to bring you up to the minute news on how Coronavirus is affecting Tampa and surrounding areas. Please consider making a one time or monthly donation to help support our staff. Every little bit helps.

Subscribe to our newsletter and follow @cl_tampabay on Twitter.

Scroll to read more Florida News articles
Join the Creative Loafing Tampa Bay Press Club

Local journalism is information. Information is power. And we believe everyone deserves access to accurate independent coverage of their community and state.
Help us keep this coverage going with a one-time donation or an ongoing membership pledge.


Join Creative Loafing Tampa Bay Newsletters

Subscribe now to get the latest news delivered right to your inbox.

We welcome readers to submit letters regarding articles and content in Creative Loafing Tampa Bay. Letters should be a minimum of 150 words, refer to content that has appeared on Creative Loafing Tampa Bay, and must include the writer's full name, address, and phone number for verification purposes. No attachments will be considered. Writers of letters selected for publication will be notified via email. Letters may be edited and shortened for space.

Email us at [email protected]